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Background: Increased Rho kinase (ROCK) activity is associated with endothelial dysfunction and vascular inflammation. This study aimed to find 
out if baseline ROCK activity is associated with the outcomes after acute coronary syndrome (ACS).
Methods: 163 Hong Kong subjects admitted for ACS were studied. Baseline ROCK activity was measured by phosphorylation of myosin binding 
subunit (MBS) in peripheral leukocytes. All the patients were followed up for 6 months or until occurrence of MACE (cardiac death, nonfatal MI, 
revascularization).
Results: By ROC analysis, the best cutoff value of baseline leukocyte ROCK activity for the prediction of 6 month MACE events were pMBS/tMBS 
ratio of 3.163 (area=0.612, sensitivity=0.607, specificity=0.611). In all the ACS patients corhort, age >65 years old, creatine phosphokinase 
peak (U/I), creatinine >200μmol/l, eGFR >60ml/min/1.73m2, heart failure symptom on presentation, Percutaneous Coronary Intervention (PCI) 
treatment in admission and baseline ROCK activity >3.163 were all significant (p<0.05) predictors of 6 month MACE outcomes from univariate 
analysis. Multivariate stepwise Cox hazard regression showed that creatinine >200μmol/l (OR=2.687, 95%CI=1.043-6.923, P=0.041), PCI treatment 
in admission (OR=0.283, 95%CI=0.097-0.823, P=0.021) and baseline ROCK activity >3.163 (OR=2.797, 95%CI=1.055-7.411, P=0.039) were 
independent predictors of the 6 month coronary events.
Conclusions: Increased Rho kinase (ROCK) activity is an independent predictor for the 6 month outcomes after ACS. Decreasing ROCK activity 
might be the treatment target to reduce the cardiovascular events in the future.
